Total assets of Jiangsu Hengrui Pharmaceuticals 2014-2022
As of December 2022, the total assets of the Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals amounted to more than 42 billion yuan, reflecting its strong growth in the last decade. The company is a market leader in oncology medications and spent almost 30 percent of its operating income on research and development.